BCL3 and nevoid basal cell carcinoma syndrome: These results suggest the existence of crosstalk between the two pathways and also demonstrate that p50/Bcl3-dependent transcriptional activity supports BCC tumor growth in this murine model and combined blockade of NFκB and Shh signaling is substantially more effective in abrogating the growth of BCCs in a mouse model of NBCCS.